Zions: NII Momentum + Buyback = Re-rating Opportunity into 2026

Hook / Thesis

Zions Bancorporation (ZION) looks set to benefit from a rising-margin backdrop and shareholder-friendly capital allocation that together create a path to visible earnings-per-share upside in 2026. The bank is profitable, conservatively levered, and trading at roughly a single-digit multiple when you consider the forward-looking case: earnings per share of $6.01 and a price-to-earnings of about 10.5 make the stock attractive if net interest income (NII) and loan mix trends normalize.

We see a clear trade: buy ZION at $62.00, place a protective stop at $57.00, and target $75.00 over a long-term (180 trading days) horizon. The rationale is simple - incremental NII from a higher rate environment, a $75 million share repurchase program announced by the board, and a 2.8%+ dividend yield combine to support both earnings and valuation. Technicals and improving short interest dynamics add tactical support for a measured long exposure.

What Zions does and why the market should care

Zions Bancorporation N.A. is a regional bank holding company operating franchises such as Zions Bank, Amegy Bank, California Bank & Trust, National Bank of Arizona, Nevada State Bank, Vectra Bank Colorado and The Commerce Bank of Washington. The business is traditional commercial and consumer banking - deposit gathering, lending, mortgage and treasury services - with a concentrated presence in Western U.S. markets.

The market cares because banks are leverage plays on the yield curve and credit cycle. When the 10-year Treasury and related short-term funding rates move higher, net interest margins generally expand for well-managed banks that can reprice assets faster than liabilities. Conversely, credit losses or unexpected charge-offs compress returns. Zions is notable for a return on equity of 12.31% and a conservative debt-to-equity ratio of 0.21, giving it both profitability and balance sheet room to absorb shocks while returning capital to shareholders.

Key numbers that support the setup

Those numbers tell a consistent story: Zions is generating cash, posting decent returns on equity and trading at modest multiples. The balance sheet is not highly levered for a bank (debt-to-equity 0.21), which limits downside in a stress scenario relative to more aggressive peers.

Recent corporate actions and technicals that matter

On 01/30/2026 the board authorized a $75 million share repurchase program and declared the regular quarterly dividend of $0.45, signaling confidence in capital generation. That buyback combined with a steadier dividend should lift EPS over time even if organic loan growth is modest. Technically, the stock sits above its 50-day SMA ($58.72) and the 10-day average is near $61.82; RSI is around 62 and MACD shows bullish momentum. Short interest has been declining from larger levels late last year to around 4.99M as of 03/31/2026 (days-to-cover ~2.68), reducing the risk of a sustained short squeeze while still leaving room for volatility given recent increases in short-volume intraday activity.

Valuation framing

At roughly $9.2 billion in market cap and a P/E near 10.5x, Zions is priced for modest earnings growth or a reversion to historical mid-teens multiples only if the NII story and buybacks accelerate. P/B of ~1.29x suggests the market is not paying a premium for franchise value today. EV/EBITDA of ~8.6x and free cash flow approaching $1 billion provide a cushion: the business can generate cash to fund both organic growth and capital returns. Put simply, the stock is not expensive on absolute multiples; the question is whether earnings and margins recover sufficiently to justify multiple expansion. We think the setup supports that outcome.

Catalysts

• Net interest income uplift as Treasury yields and bank lending rates stabilize or rise further - positive carry flows to NII and margins.
• Share repurchase execution: the $75M program announced 01/30/2026 will reduce shares outstanding and lift EPS if executed.
• Improving credit trends (lower net charge-offs) that reverse the profit headwinds from the $50M charge-off reported last year on 10/16/2025.
• Better-than-expected quarterly results that show sequential loan growth and margin expansion, prompting analyst upgrades and multiple re-rating.
• Sector sentiment recovery if regional bank stress subsides and investors rotate back into value-yielding financials.

Trade plan (actionable)

Entry: $62.00

Stop loss: $57.00

Target: $75.00

Horizon: long term (180 trading days). This horizon gives time for NII to show up in reported quarters and for the buyback to start impacting EPS. Expect volatility around quarterly prints; the stop is set below the 50-day moving average and recent technical support to allow for short-term noise while protecting the position if fundamentals deteriorate.

Position sizing and risk management

Use position sizing that limits downside to a predetermined percentage of your portfolio on a breach of the $57 stop. Review the position after each quarterly release and after material macro moves that compress regional bank multiples (e.g., major moves in the 10-year Treasury or widely reported loan losses in the sector).

Risks and counterarguments

• Credit risk / loan irregularities: The company took a $50M charge-off that drove litigation and media attention (events around 10/16/2025). More surprises in loan quality or additional charge-offs would pressure earnings and the multiple.
• Regional bank sentiment: The sector remains sensitive to headlines. A renewed sector selloff or lack of investor appetite for regional banks would constrain rerating even if Zions executes operationally.
• Mortgage and origination headwinds: Higher mortgage rates have weighed on applications and new-home sales per recent market commentary (03/20/2026). Downturns in mortgage activity reduce fee income and could offset NII gains.
• Regulatory / legal risk: Continued investigations or securities claims tied to past charge-offs could create legal costs, fines or require additional disclosures that depress the stock.
• Macroeconomic counterargument: The thesis assumes a stable-to-higher rate environment aiding NII. If the yield curve inverts further or the Fed cuts rates meaningfully, NII tailwinds could evaporate and the stock would likely underperform.

Counterargument to our thesis: One can reasonably argue Zions is already priced to reflect these idiosyncratic risks - the modest P/B and P/E show the market's skepticism. If loan irregularities prove broader than the single $50M item or if the company must materially expand reserves, the stock could remain range-bound or decline despite share repurchases.

What would change my mind

I would turn neutral or bearish if Zions reports a sequence of rising net charge-offs or materially expands provisioning, or if the board pauses or retracts the buyback program. Conversely, I would add to the position and revise the target higher if management reports sustained NII growth, a lower cost of funds paired with loan yield expansion, and consistent buyback execution that meaningfully reduces share count.

Conclusion

Zions is a pragmatic long idea: solid cash generation ($952M FCF), conservative leverage (debt-to-equity 0.21) and a supportive capital return policy give tangible paths to improved EPS and a multiple rerating. The trade is not free of risk - credit headlines and sector volatility can erase upside quickly - but the combination of valuation, corporate actions and technical momentum makes a well-sized long entry at $62.00 with a $57.00 stop and a $75.00 target a sensible way to play a 2026 NII recovery and re-rating scenario.

Key dates to watch

• Next quarterly earnings release - watch NII, loan loss provisions, and guidance for buyback pacing.
• Execution updates on the $75M repurchase program announced 01/30/2026.
• Macro moves in the 10-year Treasury and mortgage market data that affect loan demand and margins.